Doctor Jan Johansson
Resverlogix Inc., San Francisco (United States of America)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Vascular and Alzheimer's disease effects by the apoE derived ABCA1 agonist CS6253
Event: ESC Congress 2017
Topic: Basic Science
Session: Cardiovascular care - Biology II
Lowering the neutrophil to lymphocyte ratio by the BET inhibitor, apabetalone: potential implications for cardiovascular events in high risk patients
Event: ESC Congress 2017
Topic: Inflammation and microcirculation
Session: Coronary artery disease: from bench to bedside
Atherosclerosis reduction and improved glucose control the ABCA1 agonist CS6253. In vitro and in vivo mechanism of action studies
Event: ESC Congress 2017
Topic: Angiogenesis
Session: Vascular degeneration and restoration
ESC 365 is supported by
